SUTRO BIOPHARMA, INC. Interest Payable
SUTRO BIOPHARMA, INC. (STRO) had Interest Payable of $100.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2023-11-13
- 2023-09-30: Interest Payable $100.00K.
- 2023-06-30: Interest Payable $100.00K.
- 2023-03-31: Interest Payable $100.00K.
- 2022-12-31: Interest Payable $100.00K.
| Period end | Interest Payable |
|---|---|
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $100.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $100.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $100.00K 10-Q · filed 2023-11-13 |
| 2022-09-30 | $100.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $200.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $200.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $200.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $200.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $200.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $200.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $200.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $200.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $400.00K 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 |